With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression||University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD||'A' Award Grants||2016||Texas|
|CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors||St. Jude Children's Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD||Innovation Grants||2016||Tennessee|
|Enhancing Coping and Communication in Children with Cancer and Their Parents: A Novel Internet-Based Intervention||Vanderbilt University Medical Center / Bruce Compas, PhD||Psychosocial Grants||2016||Tennessee|
|Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome||St. Jude Children's Research Hospital / Lisa Jacola, PhD||Psychosocial Grants||2016||Tennessee|
|MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors||Vanderbilt University Medical Center / William Tansey, PhD||Innovation Grants||2016||Tennessee|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|Micro-environmental Regulators of Ewing sarcoma Metastasis||University of Pittsburgh / Kelly Bailey, MD/PhD||Young Investigator Grants||2016||Pennsylvania|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|